« Previous
Next »
Titles
- General clinical pharmacology considerations for neonatal studies for drugs and biological products1
- General considerations for animal studies intended to evaluate medical devices: guidance for industry and Food and Drug Administration staff1
- Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives1
- Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees1
- Georgia could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Global health security: USAID and CDC funding, activities, and assessments of countries’ capacities to address infectious disease threats before COVID-19 onset : report to Congressional committees1
- Graduate medical education: programs and residents increased during transition to single accreditor; distribution largely unchanged : report to Congressional requesters1
- Guardianship monitoring: a national survey of court practices1
- Guarding the guardians: promising practices for court monitoring1